CXL Ophthalmics’ $32 Million Series A Round of Fundraising

Mintz represented CXL Ophthalmics (CXLO) on the deal while Foley & Lardner LLP represented AXA IM Alts.CXL Ophthalmics (CXLO), a clinical-stage company developing a minimally-invasive treatment…